DOCSLIB.ORG

Public Law 115–239 115Th Congress an Act to Amend the Harmonized Tariff Schedule of the United States to Modify Temporarily Sept

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Public Law 115–239 115Th Congress an Act to Amend the Harmonized Tariff Schedule of the United States to Modify Temporarily Sept PUBLIC LAW 115–239—SEPT. 13, 2018 132 STAT. 2451 Public Law 115–239 115th Congress An Act To amend the Harmonized Tariff Schedule of the United States to modify temporarily Sept. 13, 2018 certain rates of duty. [H.R. 4318] Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, Miscellaneous Tariff Bill Act of SECTION 1. SHORT TITLE; REFERENCE; EXPIRED PROVISIONS. 2018. (a) SHORT TITLE.—This Act may be cited as the ‘‘Miscellaneous 19 USC 1 note. Tariff Bill Act of 2018’’. (b) REFERENCE.—Except as otherwise expressly provided, when- ever in this Act an amendment or repeal is expressed in terms of an amendment to, or repeal of, a chapter, subchapter, note, additional U.S. note, heading, subheading, or other provision, the reference shall be considered to be made to a chapter, subchapter, note, additional U.S. note, heading, subheading, or other provision of the Harmonized Tariff Schedule of the United States. (c) EXPIRED PROVISIONS.—Subchapter II of chapter 99 is amended— (1) by striking heading 9902.01.01 and all headings that follow through the end of such subchapter; and (2) by striking U.S. Note 7 and U.S. Notes 13 through 19. SEC. 2. FROZEN, BOILED GLUTINOUS CORN. Subchapter II of chapter 99 is amended by inserting the fol- lowing new heading: ‘‘ 9902.01.01 Frozen, boiled glutinous corn (other than sweet corn), not reduced in size (provided for in subheading 0710.80.70) ......................... Free No change No change On or before 12/31/2020 ... ’’. SEC. 3. MUSTARD SEED OIL. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.02 Mustard seed oil and its fractions, other than crude, not denatured, not chemi- cally modified (provided for in subheading 1514.99.90) Free No change No change On or before 12/31/2020 ... ’’. VerDate Sep 11 2014 01:46 Sep 05, 2019 Jkt 089139 PO 00239 Frm 00001 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL239.115 PUBL239 smartinez on DSK30VT082PROD with PUBLAWS 132 STAT. 2452 PUBLIC LAW 115–239—SEPT. 13, 2018 SEC. 4. COCOA POWDER. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.03 Cocoa powder, not con- taining added sugar or other sweetening matter (provided for in subheading 1805.00.00) ......................... Free No change No change On or before 12/31/2020 ... ’’. SEC. 5. ARTICHOKES, IN VINEGAR. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.04 Artichokes, prepared or preserved by vinegar or acetic acid (provided for in subheading 2001.90.25) ..... 7.2% No change No change On or before 12/31/2020 ... ’’. SEC. 6. PEPPERONCINI, PRESERVED BY VINEGAR, IN GLASS JARS. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.05 Pepperoncini, prepared or preserved by vinegar or acetic acid and presented in glass jars (provided for in subheading 2001.90.38) Free No change No change On or before 12/31/2020 ... ’’. SEC. 7. PEPPERONCINI, VINEGAR PRESERVED, NOT IN GLASS JARS. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.06 Pepperoncini, prepared or preserved by vinegar or acetic acid and presented in containers other than glass jars (provided for in subheading 2001.90.38) ..... Free No change No change On or before 12/31/2020 ... ’’. SEC. 8. MINCED PIMIENTO STUFFED GREEN OLIVES. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.07 Olives, green in color, stuffed with minced pi- miento, the foregoing in brine and presented in glass containers, other than place packed (pro- vided for in subheading 2005.70.25) ......................... Free No change No change On or before 12/31/2020 ... ’’. VerDate Sep 11 2014 01:46 Sep 05, 2019 Jkt 089139 PO 00239 Frm 00002 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL239.115 PUBL239 smartinez on DSK30VT082PROD with PUBLAWS PUBLIC LAW 115–239—SEPT. 13, 2018 132 STAT. 2453 SEC. 9. PIMIENTOS. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.08 Pimientos, prepared or pre- served otherwise than by vinegar or acetic acid, not frozen (provided for in sub- heading 2005.99.50) ........... Free No change No change On or before 12/31/2020 ... ’’. SEC. 10. PEPPERONCINI, OTHER THAN PRESERVED BY VINEGAR. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.09 Pepperoncini, prepared or preserved otherwise than by vinegar or acetic acid, not frozen (provided for in subheading 2005.99.55) ..... Free No change No change On or before 12/31/2020 ... ’’. SEC. 11. ARTICHOKES, OTHER THAN IN VINEGAR. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.10 Artichokes, prepared or preserved otherwise than by vinegar or acetic acid, not frozen (provided for in subheading 2005.99.80) ..... 12.7% No change No change On or before 12/31/2020 ... ’’. SEC. 12. DRIED STRAWBERRIES. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.11 Strawberries, brined and then oven-dried or tunnel- dried, the foregoing infused with sugar (provided for in subheading 2008.80.00) ..... Free No change No change On or before 12/31/2020 ... ’’. SEC. 13. EDIBLE POWDER CONTAINING CONJUGATED LINOLEIC ACID. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.12 Edible powder containing conjugated linoleic acid (CAS Nos. 2540–56–9 and 2420–56–6) containing over 10 percent by weight of milk solids (provided for in subheading 2106.90.82) ..... Free No change No change On or before 12/31/2020 ... ’’. VerDate Sep 11 2014 01:46 Sep 05, 2019 Jkt 089139 PO 00239 Frm 00003 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL239.115 PUBL239 smartinez on DSK30VT082PROD with PUBLAWS 132 STAT. 2454 PUBLIC LAW 115–239—SEPT. 13, 2018 SEC. 14. NICOTINE GUM. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.13 Gum containing nicotine and containing synthetic sweetening agents (e.g., saccharin) instead of sugar (provided for in subheading 2106.90.98) ......................... 5.8% No change No change On or before 12/31/2020 ... ’’. SEC. 15. COCONUT WATER JUICE BLENDS. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.14 Coconut water juice blends, not from con- centrate, packaged for re- tail sale (provided for in subheading 2009.90.40) ..... Free No change No change On or before 12/31/2020 ... ’’. SEC. 16. COCONUT WATER IN PAPER CARTONS. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.15 Coconut water, not from concentrate, not containing added sugar or other sweetening matter, pack- aged for retail sale in paper-based cartons (pro- vided for in subheading 2009.89.60) ......................... Free No change No change On or before 12/31/2020 ... ’’. SEC. 17. FLAVORED COCONUT WATER. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.16 Coconut water not from concentrate, flavored, pack- aged for retail sale (pro- vided for in subheading 2009.89.60) ......................... Free No change No change On or before 12/31/2020 ... ’’. SEC. 18. COCONUT WATER IN PET BOTTLES. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: VerDate Sep 11 2014 01:46 Sep 05, 2019 Jkt 089139 PO 00239 Frm 00004 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL239.115 PUBL239 smartinez on DSK30VT082PROD with PUBLAWS PUBLIC LAW 115–239—SEPT. 13, 2018 132 STAT. 2455 ‘‘ 9902.01.17 Coconut water, not from concentrate, not containing added sugar or other sweetening, certified by the importer as from conven- tionally grown (non-or- ganic) coconuts, packaged for retail sale in 500 milli- liter polyethyl-ene terephthalate bottles (pro- vided for in subheading 2009.89.60) ......................... Free No change No change On or before 12/31/2020 ... ’’. SEC. 19. ISODODECANE (CAS 93685–81–5). Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.18 Light oil fractions con- taining more than 50 per- cent by weight of isododecane (CAS No. 93685–81–5) (provided for in subheading 2710.12.90) Free No change No change On or before 12/31/2020 ... ’’. SEC. 20. ISOHEXADECANE (CAS NO. 93685–80–4). Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.19 Medium oil fractions con- taining more than 50 per- cent by weight of isohexadecane (CAS No. 93685–80–4) (provided for in subheading 2710.19.90) Free No change No change On or before 12/31/2020 ... ’’. SEC. 21. SODIUM. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.20 Sodium, containing more than 200 ppm of calcium (CAS No. 7440–23–5) (pro- vided for in subheading 2805.11.00) ......................... 2.5% No change No change On or before 12/31/2020 ... ’’. SEC. 22. SODIUM CONTAINING NOT MORE THAN 200 PPM OF CALCIUM. Subchapter II of chapter 99 is amended by inserting in numer- ical sequence the following new heading: ‘‘ 9902.01.21 Sodium, containing not more than 200 ppm of cal- cium (CAS No.
Load more

Recommended publications
  • Synergistic Effect of Acids and HFIP on Friedel-Crafts Reactions of Alcohols and Cyclopropanes Vuk Vukovic
    Synergistic effect of acids and HFIP on Friedel-Crafts reactions of alcohols and cyclopropanes Vuk Vukovic To cite this version: Vuk Vukovic. Synergistic effect of acids and HFIP on Friedel-Crafts reactions of alcohols andcy- clopropanes. Organic chemistry. Université de Strasbourg, 2018. English. NNT : 2018STRAF068. tel-02918037 HAL Id: tel-02918037 https://tel.archives-ouvertes.fr/tel-02918037 Submitted on 20 Aug 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ DE STRASBOURG ÉCOLE DOCTORALE DES SCIENCES CHIMIQUES (ED 222) Laboratoire de Catalyse Chimique Institut de Science et d'Ingénierie Supramoléculaires (UMR 7006) THÈSE de DOCTORAT présentée par Vuk VUKOVIĆ soutenue le 14 décembre 2018 pour obtenir le grade de : Docteur de l’Université de Strasbourg Discipline/ Spécialité : Chimie organique Synergistic Effect of Acids and HFIP on Friedel-Crafts Reactions of Alcohols and Cyclopropanes THESE dirigée par : Prof. MORAN Joseph Université de Strasbourg RAPPORTEURS : Prof. THIBAUDEAU Sébastien Université de Poitiers Prof. GANDON Vincent Université Paris-Sud 11 EXAMINATEUR: Dr WENCEL-DELORD Joanna Université de Strasbourg Synergistic Effect of Acids and HFIP on Friedel-Crafts Reactions of Alcohols and Cyclopropanes Table of Contents page Table of Contents I Acknowledgement and Dedication V List of Abbreviations XIII Résumé XVII Chapter 1.
    [Show full text]
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • Densifying Metal Hydrides with High Temperature and Pressure
    3,784,682 United States Patent Office Patented Jan. 8, 1974 feet the true density. That is, by this method only theo- 3,784,682 retical or near theoretical densities can be obtained by DENSIFYING METAL HYDRIDES WITH HIGH making the material quite free from porosity (p. 354). TEMPERATURE AND PRESSURE The true density remains the same. Leonard M. NiebylsM, Birmingham, Mich., assignor to Ethyl Corporation, Richmond, Va. SUMMARY OF THE INVENTION No Drawing. Continuation-in-part of abandoned applica- tion Ser. No. 392,370, Aug. 24, 1964. This application The process of this invention provides a practical Apr. 9,1968, Ser. No. 721,135 method of increasing the true density of hydrides of Int. CI. COlb 6/00, 6/06 metals of Groups II-A, II-B, III-A and III-B of the U.S. CI. 423—645 8 Claims Periodic Table. More specifically, true densities of said 10 metal hydrides may be substantially increased by subject- ing a hydride to superatmospheric pressures at or above ABSTRACT OF THE DISCLOSURE fusion temperatures. When beryllium hydride is subjected A method of increasing the density of a hydride of a to this process, a material having a density of at least metal of Groups II-A, II-B, III-A and III-B of the 0.69 g./cc. is obtained. It may or may not be crystalline. Periodic Table which comprises subjecting a hydride to 15 a pressure of from about 50,000 p.s.i. to about 900,000 DESCRIPTION OF THE PREFERRED p.s.i. at or above the fusion temperature of the hydride; EMBODIMENT i.e., between about 65° C.
    [Show full text]
  • California Proposition 65 Toxicity List
    STATE OF CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY OFFICE OF ENVIRONMENTAL HEALTH HAZARD ASSESSMENT SAFE DRINKING WATER AND TOXIC ENFORCEMENT ACT OF 1986 CHEMICALS KNOWN TO THE STATE TO CAUSE CANCER OR REPRODUCTIVE TOXICITY 4-Mar-05 The Safe Drinking Water and Toxic Enforcement Act of 1986 requires that the Governor revise and Chemical Type of Toxicity CAS No. Date Listed A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) cancer 26148685 1-Jan-90 Acetaldehyde cancer 75070 1-Apr-88 Acetamide cancer 60355 1-Jan-90 Acetazolamide developmental 59665 20-Aug-99 Acetochlor cancer 34256821 1-Jan-89 Acetohydroxamic acid developmental 546883 1-Apr-90 2-Acetylaminofluorene cancer 53963 1-Jul-87 Acifluorfen cancer 62476599 1-Jan-90 Acrylamide cancer 79061 1-Jan-90 Acrylonitrile cancer 107131 1-Jul-87 Actinomycin D cancer 50760 1-Oct-89 Actinomycin D developmental 50760 1-Oct-92 Adriamycin (Doxorubicin hydrochloride) cancer 23214928 1-Jul-87 AF-2;[2-(2-furyl)-3-(5-nitro-2-furyl)]acrylamide cancer 3688537 1-Jul-87 Aflatoxins cancer --- 1-Jan-88 Alachlor cancer 15972608 1-Jan-89 Alcoholic beverages, when associated with alcohol abuse cancer --- 1-Jul-88 Aldrin cancer 309002 1-Jul-88 All-trans retinoic acid developmental 302794 1-Jan-89 Allyl chloride Delisted October 29, 1999 cancer 107051 1-Jan-90 Alprazolam developmental 28981977 1-Jul-90 Altretamine developmental, male 645056 20-Aug-99 Amantadine hydrochloride developmental 665667 27-Feb-01 Amikacin sulfate developmental 39831555 1-Jul-90 2-Aminoanthraquinone cancer 117793 1-Oct-89 p -Aminoazobenzene cancer
    [Show full text]
  • Evaluation of Fluralaner and Afoxolaner Treatments to Control Flea
    Dryden et al. Parasites & Vectors (2016) 9:365 DOI 10.1186/s13071-016-1654-7 RESEARCH Open Access Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA Michael W. Dryden1*, Michael S. Canfield2, Kimberly Kalosy1, Amber Smith1, Lisa Crevoiserat1, Jennifer C. McGrady1, Kaitlin M. Foley1, Kathryn Green2, Chantelle Tebaldi2, Vicki Smith1, Tashina Bennett1, Kathleen Heaney3, Lisa Math3, Christine Royal3 and Fangshi Sun3 Abstract Background: A study was conducted to evaluate and compare the effectiveness of two different oral flea and tick products to control flea infestations, reduce pruritus and minimize dermatologic lesions over a 12 week period on naturally infested dogs in west central FL USA. Methods: Thirty-four dogs with natural flea infestations living in 17 homes were treated once with a fluralaner chew on study day 0. Another 27 dogs living in 17 different homes were treated orally with an afoxolaner chewable on day 0, once between days 28–30 and once again between days 54–60. All products were administered according to label directions by study investigators. Flea populations on pets were assessed using visual area counts and premise flea infestations were assessed using intermittent-light flea traps on days 0, 7, 14, 21, and once between days 28–30, 40–45, 54–60 and 82–86. Dermatologic assessments were conducted on day 0 and once monthly. Pruritus assessments were conducted by owners throughout the study. No concurrent treatments for existing skin disease (antibiotics, anti-inflammatories, anti-fungals) were allowed.
    [Show full text]
  • B Commission Regulation (Eu)
    02010R0037 — EN — 29.09.2018 — 035.001 — 1 This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document ►B COMMISSION REGULATION (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (Text with EEA relevance) (OJ L 15, 20.1.2010, p. 1) Amended by: Official Journal No page date ►M1 Commission Regulation (EU) No 758/2010 of 24 August 2010 L 223 37 25.8.2010 ►M2 Commission Regulation (EU) No 759/2010 of 24 August 2010 L 223 39 25.8.2010 ►M3 Commission Regulation (EU) No 761/2010 of 25 August 2010 L 224 1 26.8.2010 ►M4 Commission Regulation (EU) No 890/2010 of 8 October 2010 L 266 1 9.10.2010 ►M5 Commission Regulation (EU) No 914/2010 of 12 October 2010 L 269 5 13.10.2010 ►M6 Commission Regulation (EU) No 362/2011 of 13 April 2011 L 100 26 14.4.2011 ►M7 Commission Regulation (EU) No 363/2011 of 13 April 2011 L 100 28 14.4.2011 ►M8 Commission Implementing Regulation (EU) No 84/2012 of 1 L 30 1 2.2.2012 February 2012 ►M9 Commission Implementing Regulation (EU) No 85/2012 of 1 L 30 4 2.2.2012 February 2012 ►M10 Commission Implementing Regulation (EU) No 86/2012 of 1 L 30 6 2.2.2012 February 2012 ►M11 Commission
    [Show full text]
  • Identification of Transcriptome and Fluralaner Responsive Genes in The
    Jia et al. BMC Genomics (2020) 21:120 https://doi.org/10.1186/s12864-020-6533-0 RESEARCH ARTICLE Open Access Identification of transcriptome and fluralaner responsive genes in the common cutworm Spodoptera litura Fabricius, based on RNA-seq Zhong-Qiang Jia1, Di Liu1, Ying-Chuan Peng1,3, Zhao-Jun Han1, Chun-Qing Zhao1* and Tao Tang2* Abstract Background: Fluralaner is a novel isoxazoline insecticide with a unique action site on the γ-aminobutyric acid receptor (GABAR), shows excellent activity on agricultural pests including the common cutworm Spodoptera litura, and significantly influences the development and fecundity of S. litura at either lethal or sublethal doses. Herein, Illumina HiSeq Xten (IHX) platform was used to explore the transcriptome of S. litura and to identify genes responding to fluralaner exposure. Results: A total of 16,572 genes, including 451 newly identified genes, were observed in the S. litura transcriptome and annotated according to the COG, GO, KEGG and NR databases. These genes included 156 detoxification enzyme genes [107 cytochrome P450 enzymes (P450s), 30 glutathione S-transferases (GSTs) and 19 carboxylesterases (CarEs)] and 24 insecticide-targeted genes [5 ionotropic GABARs, 1 glutamate-gated chloride channel (GluCl), 2 voltage-gated sodium channels (VGSCs), 13 nicotinic acetylcholine receptors (nAChRs), 2 acetylcholinesterases (AChEs) and 1 ryanodine receptor (RyR)]. There were 3275 and 2491 differentially expressed genes (DEGs) in S. litura treated with LC30 or LC50 concentrations of fluralaner, respectively. Among the DEGs, 20 related to detoxification [16 P450s, 1 GST and 3 CarEs] and 5 were growth-related genes (1 chitin and 4 juvenile hormone synthesis genes).
    [Show full text]
  • WO 2015/014733 Al 5 February 2015 (05.02.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2015/014733 Al 5 February 2015 (05.02.2015) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07D 233/64 (2006.01) C07D 403/06 (2006.01) kind of national protection available): AE, AG, AL, AM, A 43/40 (2006.01) C07D 239/26 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A 43/50 (2006.01) C07D 417/06 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, A0 43/54 (2006.01) C07D 249/08' (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, A0 43/653 (2006.01) C07D 213/57 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, C07D 401/06 (2006.01) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (21) International Application Number: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, PCT/EP2014/065994 SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (22) International Filing Date: TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, 25 July 2014 (25.07.2014) ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 2256/DEL/2013 29 July 2013 (29.07.2013) IN TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (71) Applicant: SYNGENTA PARTICIPATIONS AG MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, [CH/CH]; Schwarzwaldallee 215, CH-4058 Basel (CH).
    [Show full text]
  • Alar Five Years Later
    Alar Five Years Later by Kenneth Smith This special report was written for the American Council on Science and Health by Kenneth Smith, Editorial Writer of The Washington Times as a follow-up to the two previous reports: Alar One Year Later andAlar Three Years Later. ACSH gratefully acknowledges the comments and contributions of the following individuals who reviewed one or more editions of this report: F. J. Francis, Ph.D. University of Massachusetts Lois S. Gold, Ph.D. University of California, Berkeley Thomas H. Jukes, Ph.D. University of California, Berkeley Roger P. Maickel, Ph.D. Purdue University A. Alan Moghissi, Ph.D. Temple University Robert E. Olson, M.D., Ph.D. SUNY at Stony Brook Thomas W. Orme, Ph.D. American Council on Science and Health Edward G. Remmers, Sc.D. American Council on Science and Health Joseph Rosen, Ph.D. Rutgers University Fredrick J. Stare, M.D., Ph.D. Harvard School of Public Health Elizabeth M. Whelan, Sc.D., M.P.H. American Council on Science and Health “As a pediatric surgeon, as well as the nation’s former surgeon general, I care deeply about the health of children — and if Alar ever posed a health hazard, I would have said so then and would say so now. When used in the regulated, approved manner as Alar was before it was with- drawn in 1989, Alar-treated apple products posed no hazard to the health of children or adults.” — C. Everett Koop, M.D. Executive Summary In early 1989, this country suffered the public relations equivalent of a natural disaster, one that most scientists now believe should never have occurred.
    [Show full text]
  • Evaluation of Fluralaner As an Oral Acaricide to Reduce Tick Infestation
    Pelletier et al. Parasites Vectors (2020) 13:73 https://doi.org/10.1186/s13071-020-3932-7 Parasites & Vectors RESEARCH Open Access Evaluation of furalaner as an oral acaricide to reduce tick infestation in a wild rodent reservoir of Lyme disease Jérôme Pelletier1,2,3*, Jean‑Philippe Rocheleau2,4, Cécile Aenishaenslin1,2,3, Francis Beaudry5, Gabrielle Dimitri Masson1,2, L. Robbin Lindsay6, Nicholas H. Ogden2,7, Catherine Bouchard2,7 and Patrick A. Leighton1,2,3 Abstract Background: Lyme disease (LD) is an increasing public health threat in temperate zones of the northern hemisphere, yet relatively few methods exist for reducing LD risk in endemic areas. Disrupting the LD transmission cycle in nature is a promising avenue for risk reduction. This experimental study evaluated the efcacy of furalaner, a recent oral aca‑ ricide with a long duration of efect in dogs, for killing Ixodes scapularis ticks in Peromyscus maniculatus mice, a known wildlife reservoir for Borrelia burgdorferi in nature. Methods: We assigned 87 mice to 3 furalaner treatment groups (50 mg/kg, 12.5 mg/kg and untreated control) administered as a single oral treatment. Mice were then infested with 20 Ixodes scapularis larvae at 2, 28 and 45 days post‑treatment and we measured efcacy as the proportion of infesting larvae that died within 48 h. At each infesta‑ tion, blood from 3 mice in each treatment group was tested to obtain furalaner plasma concentrations (C p). Results: Treatment with 50 mg/kg and 12.5 mg/kg furalaner killed 97% and 94% of infesting larvae 2 days post‑treat‑ ment, but no signifcant efect of treatment on feeding larvae was observed 28 and 45 days post‑treatment.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,586,617 B1 Tabuchi Et Al
    USOO65866.17B1 (12) United States Patent (10) Patent No.: US 6,586,617 B1 Tabuchi et al. (45) Date of Patent: Jul. 1, 2003 (54) SULFONAMIDE DERIVATIVES JP 63-307851 12/1988 JP 1-156952 6/1989 (75) Inventors: Takanori Tabuchi, Tsukuba (JP); WO 96/36596 11/1996 WO 97/24135 7/1997 Tetsuhiro Yamamoto, Toride (JP); WO 97/31910 9/1997 Masaharu Nakayama, Tsukuba (JP) WO 98/45.255 10/1998 (73) Assignee: Sumitomo Chemical Takeda Agro WO 99/06037 2/1999 Company, Limited, Tokyo (JP) WO OO/50391 8/2000 OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 Derek R. Buckle et al., “Inhibition of Cyclic Nucleotide U.S.C. 154(b) by 0 days. Phosphodiesterase by Derivatives of 1,3-Bis(cyclopropyl methyl)xanthine”, J. Med. Chem., vol. 37, No. 4, pp. (21) Appl. No.: 09/958,953 476-485, 1994. (22) PCT Filed: Apr. 17, 2000 Francisca Lopes et al., “Acyloxymethyl as a Drug Protecting Group. Part 6: N-Acyloxymethyl- and N-Aminocarbony (86) PCT No.: PCT/JP00/02764 loxy)methylsulfonamides as Prodrugs of Agents Contain S371 (c)(1), ing a Secondary Sulfonamide Group”, Bioorganic & (2), (4) Date: Dec. 18, 2001 Medicinal Chemistry, vol. 8, No. 4, pp. 707-716, 2000. J.S. Sukla et al., “Studies on Some Newer Possible Biologi (87) PCT Pub. No.: WO00/65913 cally Active Agents: Part II. Synthesis of N-(-aminopropyl)-2-heterocyclic-p-arylidene aminoben PCT Pub. Date: Nov. 9, 2000 ZeneSulphonamides and N(-aminopropyl)-2-heterocyclic (30) Foreign Application Priority Data Sulphanalamides and their Antibacterial Activity, J.
    [Show full text]
  • Toxicological Profile for Hydrazines. US Department Of
    TOXICOLOGICAL PROFILE FOR HYDRAZINES U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry September 1997 HYDRAZINES ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. HYDRAZINES iii UPDATE STATEMENT Toxicological profiles are revised and republished as necessary, but no less than once every three years. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE, E-29 Atlanta, Georgia 30333 HYDRAZINES vii CONTRIBUTORS CHEMICAL MANAGER(S)/AUTHOR(S): Gangadhar Choudhary, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Hugh IIansen, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Steve Donkin, Ph.D. Sciences International, Inc., Alexandria, VA Mr. Christopher Kirman Life Systems, Inc., Cleveland, OH THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS: 1 . Green Border Review. Green Border review assures the consistency with ATSDR policy. 2 . Health Effects Review. The Health Effects Review Committee examines the health effects chapter of each profile for consistency and accuracy in interpreting health effects and classifying end points. 3. Minimal Risk Level Review. The Minimal Risk Level Workgroup considers issues relevant to substance-specific minimal risk levels (MRLs), reviews the health effects database of each profile, and makes recommendations for derivation of MRLs. HYDRAZINES ix PEER REVIEW A peer review panel was assembled for hydrazines. The panel consisted of the following members: 1. Dr.
    [Show full text]